Caliper Technologies Names David Milligan, Abbott Chief Scientific Officer, to Board.PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif.--(BUSINESS WIRE)--Nov. 26, 1996--Caliper Technologies Corporation today announced the election of David V. Milligan, Ph.D., to the company's board of directors. Dr. Milligan is currently senior vice president and chief scientific officer of Abbott Laboratories Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals and health care company. It has over 65,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, a neighborhood of North Chicago, Illinois. . "David Milligan brings to our board a wealth of experience in leading research and development for both diagnostic and pharmaceutical products," said Michael R. Knapp, Ph.D., Caliper caliper Instrument that consists of two adjustable legs or jaws for measuring the dimensions of material parts. Spring calipers have an adjusting screw and nut; firm-joint calipers use friction at the joint to hold the legs unmoving. vice president of science and technology. "We greatly look forward to having his guidance as Caliper advances its first products to the marketplace." Dr. Milligan has been an employee of Abbott since 1979, where he has held a series of increasingly responsible management roles related to research and development. Prior to joining Abbott, he held senior management positions at such companies as Xonics Medical Systems, Litton Dental Products, and Litton Medical Systems. He received M.S. and Ph.D. degrees in organic chemistry from the University of Illinois University of Illinois may refer to:
. Caliper Technologies Corporation was founded to develop and commercialize new automated tools for biochemical analysis that offer the functional equivalent of a chemistry laboratory on a microchip. The company is applying advanced microfabrication from the semiconductor industry to the automated handling of fluids in order to develop rapid, affordable and easy-to-use systems for a variety of research, industrial and medical diagnostic applications. In doing so, Caliper expects to fundamentally change the way that chemical, biological and clinical information is generated and used. CONTACT: Caliper Technologies Michael R. Knapp, Ph.D. Vice President of Science & Technology 415/842-0703 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion